Oncternal Therapeutics
ONCT · NASDAQ
$0.5266−$0.1673 (−24.11%)TodayMarket closed ·
No price history for this range.
Who owns ONCT
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 9.3% of ONCT’s shares.
- Shanghai Pharmaceutical USA Inc6.0%
- Breitmeyer James B1.1%
- Hale (David F)1.1%
- Wills (Robert James)0.3%
- Next 6 largest institutions0.8%
- All other shareholders90.7%
| Holder | Shares | % of shares |
|---|---|---|
| Shanghai Pharmaceutical USA Inc | 177.22K | 5.99% |
| Breitmeyer James B | 32.78K | 1.11% |
| Hale (David F) | 31.30K | 1.06% |
| Wills (Robert James) | 10.00K | 0.34% |
| Vincent (Richard G) | 7.36K | 0.25% |
| Yazji (Salim M.D.) | 6.43K | 0.22% |
| Carter (Michael G) | 3.60K | 0.12% |
| Krishnan Rajesh | 2.20K | 0.07% |
| Kaufmann (Gunnar F) | 1.83K | 0.06% |
| Acadian Asset Management LLC | 1.83K | 0.06% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| Fidelity Extended Market Index Fund | 14.63K | 0.49% |
| Fidelity Total Market Index Fund | 4.03K | 0.14% |
| Fidelity Series Total Market Index Fund | 3.30K | 0.11% |
| PWC Northern Trust Extended Equity Market Index | 1.62K | 0.05% |
| DFA U.S. Targeted Value Portfolio | 1.60K | 0.05% |
Short interest
Settled Nov 29, 2024
- Shares short
- 138.62K
- Days to cover
- 1.00
- % of shares outstanding
- 4.68%
- Average daily volume
- 230.44K
- Change since last report
- +875.5%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.